New Hong Kong Listing Rules Welcome Emerging and Innovative Companies
View Debevoise InDepth
Key takeaways:
- Permitting the listing of high growth and innovative companies with weighted
voting right (“WVR”) structures, or companies referred to as having “dual-class
shares.”
- Permitting the listing of biotech companies that do not presently meet the pre-existing financial eligibility criteria under the current Main Board listing rules.
- Creating a new concessionary route to encourage companies with primary listings on the NYSE, NASDAQ or the main board of the London Stock Exchange to apply for a secondary listing on the HKEx Main Board.